These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 64717)

  • 1. Prostaglandin E for impending gangrene.
    Neilsen PE; Holstein P; Neilsen SL
    Lancet; 1977 Jan; 1(8004):192. PubMed ID: 64717
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular effect of prostaglandin (PGE1) infused into the femoral artery in normals and patients with occlusive arterial disease.
    Nielsen PE; Holstein P; Nielsen SL; Poulsen HL
    Bibl Anat; 1975; 13():305-6. PubMed ID: 1231765
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.
    Hirai M; Nanki M; Nakayama R
    Angiology; 1985 Jul; 36(7):407-13. PubMed ID: 4040721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical re-establishment of the arterial circulation in the leg in Buerger's disease--with special reference to the efficacy of prostaglandin E1 used concomitantly.
    Okamoto Y; Nakayama K; Watanabe H; Osaragi M
    Nihon Geka Hokan; 1981 May; 50(3):501-8. PubMed ID: 7197904
    [No Abstract]   [Full Text] [Related]  

  • 5. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD; Kawai S; Karadedos C; Bartels D
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1624-5. PubMed ID: 699778
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA; Jogestrand T; Kaijser L; Olsson AG
    Lakartidningen; 1977 Aug; 74(31):2629-33. PubMed ID: 895269
    [No Abstract]   [Full Text] [Related]  

  • 7. [Are amputations avoidable ?].
    Kreutzberg K
    Fortschr Med; 1986 Jul; 104(25):51. PubMed ID: 3744257
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification of collateral arteries by intra-arterial prostaglandin El infusion].
    Rudofsky G
    Vasa Suppl; 1987; 20():215-7. PubMed ID: 3480596
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of peripheral circulation disorders with 1-benzyl-1-(3-dimethyl-amino-propoxy)-cycloheptane].
    Denck H
    Wien Med Wochenschr; 1973 Mar; 123(11):174-8. PubMed ID: 4692075
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of peripheral arterial occlusive disease in stage IIb with intermittent short-term infusion of prostaglandin E1.
    Zanke BW; Hach W; Ozen Y; Sauerwein G
    Vasa Suppl; 1987; 17():36-8. PubMed ID: 3470964
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin E1 in chronic arterial disease--a multicenter study.
    Trübestein G; Diehm C; Gruss JD; Horsch S
    Vasa Suppl; 1987; 17():39-43. PubMed ID: 3470965
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular reconstruction in the diabetic patient.
    Moore WS; Malone JM
    Angiology; 1978 Oct; 29(10):741-8. PubMed ID: 717836
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery.
    Fietze-Fischer B; Gruss JD; Bartels D; Vargas-Montano H; Stritter W
    Vasa Suppl; 1987; 17():23-5. PubMed ID: 3470961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prophylaxis and treatment of thromboses of the deep leg veins with acetylsalicylic acid (author's transl)].
    Breddin K; Scharrer I
    Munch Med Wochenschr; 1973 Nov; 115(48):2208-12. PubMed ID: 4801302
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of blood pressure in all toes in arterial occlusive disease of the leg.
    Hirai M; Kawai S; Ohta T; Seko T; Shionoya S
    Angiology; 1982 Jun; 33(6):418-26. PubMed ID: 7091772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE1 in arterial occlusive disease stage III and IV.
    Bruch HP; Hörl M; Schindler G
    Vasa Suppl; 1987; 17():26-31. PubMed ID: 3470962
    [No Abstract]   [Full Text] [Related]  

  • 17. The physiopathologic characteristics of superficial femoral artery occlusion.
    McCombs PR
    Surg Gynecol Obstet; 1979 May; 148(5):775-84. PubMed ID: 432795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolytic treatment of severe arteriopathies of the lower limbs].
    Bonnet J; Brottier L; Colle JP; Bricaud H
    Haemostasis; 1986; 16 Suppl 4():90-3. PubMed ID: 3770562
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD)--a preliminary report on a placebo-controlled double-blind study.
    Diehm C; Stammler F; Hübsch-Müller C; Eckstein HH; Simini B
    Vasa Suppl; 1987; 17():52-6. PubMed ID: 3551154
    [No Abstract]   [Full Text] [Related]  

  • 20. Pressure, flow and peripheral resistance measurements during surgery for femoro-popliteal occlusion (preliminary observations on 21 limbs).
    Bliss BP
    Scand J Clin Lab Invest Suppl; 1973; 128():179-83. PubMed ID: 4271778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.